Given the expression of Slc12a8 decreases in the LH over age, it will also be of great interest to develop compounds that could activate the function of Slc12a8 in those specific neurons and prevent or treat age-associated sarcopenia and frailty. The gene discussed is PLOD1; the disease is sarcopenia.